GENE ONLINE|News &
Opinion
Blog

Nasal Spray
The First-Ever Nasal Spray for Anaphylactic Shock Gets FDA Approval
2024-08-12
Vistagen’s Positive Phase 3 Results for Social Anxiety Treatment
2023-08-10
Emergent BioSolutions’ Over-The-Counter Naloxone Nasal Spray Receives FDA Greenlight
2023-03-30
Pfizer’s Fast-Acting Migraine Nasal Spray Takes Home US Approval
2023-03-13
FDA
First Nasal Spray for Allergies Now Available Over-the-Counter
2022-07-13
Google-Backed Leyden Labs Closes $140 Million Series B to Fight Viruses with Nasal Spray
2022-01-26
Oyster Point’s Nasal Spray for Dry Eyes Notches FDA Approval
2021-10-19
VistaGen’s Antidepressant Nasal Spray Succeeds Phase 2a Trial
2020-02-22
LATEST
David vs. Goliath: Taiwan’s PGI Wins $23M Settlement in Sequencing Patent Dispute with U.S. PacBio
2026-03-13
Gut Microbiome Composition Predicts Long-term Cardiometabolic Health Outcomes in Diverse Urban Populations
2026-03-12
NVIDIA Ahead of GTC 2026: Markets Focus on Data Center Strength, PC Expansion, and the Next Technical Breakout
2026-03-12
Global and APAC Biopharma Watch: Capital Raising, Clinical Expansion, and Industry Moves in Focus
2026-03-12
Dividend Exchange Rate for Q3 2025 Announced by DEC on March 12, 2026
2026-03-12
NewHydrogen Files International Patent Application for ThermoLoop Technology to Enhance Hydrogen Production Efficiency
2026-03-12
BioGene Therapeutics Inc. Appoints Raj S. Pruthi as Director
2026-03-12
Scroll to Top